Senior Director/Head of Clinical Data Management at Alector

Date of management change: February 24, 2025 

What Happened?

 

About the Company

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.

 

About the Person

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Stevens Phil, Cohen Wendy, McFadden Bruce, Mandel Paul, Gupta Anchal, Cleland Thomas, Greenberg Paul, Orgeron Craig, Stover Viviane, Nelson Jayson, Searle Anne

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.